`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ROXANE LABORATORIES, INC.
`
`Petitioner,
`
`NOVARTIS AG
`
`Patent Owner
`
`U.S. Patent No. 9,006,224
`
`Inter Partes Review N0.: Unassigned
`
`PETITIONER ROXANE LABORATORIES, INC.’S POWER OF
`ATTORNEY FOR PETITION FOR INTER PARTES REVIEW OF U.S.
`
`PATENT NO. 9,006,224
`
`
`
`Roxane Laboratories, Inc.
`
`Inter Partes Review of USP 9,006,224
`
`Petitioner Roxane Laboratories, Inc. hereby appoints the following
`
`practitioners as its attorneys to act on behalf in all matters associated with the
`
`above-captioned Petition for Inter Partes Review of U.S. Patent No. 9,006,224:
`
`
`
`Lead Counsel
`
`Back-up Counsel
`
`Keith A. Zullow
`
`Marta E. Delsignore, Ph.D.
`
`(Reg. No. 37,975)
`
`(Reg. No. 32,689)
`
`GOODWIN PROCTER LLP
`
`GOODWIN PROCTER LLP
`
`The New York Times Building
`
`he New York Times Building
`
`620 Eighth Avenue
`
`620 Eighth Avenue
`
`New York, NY 10018-1405
`
`New York, New York 10018-1405
`
`Tel: 212-813-8846
`
`el: 212-813-8800
`
`Fax: 646-558-4226
`
`Fax: 646-558-4079
`
`kzullow@goodwinprocter.com
`
`mdelsignore@goodwinprocter.com
`
`
`
`Roxane Laboratories, Inc.
`Inter Partes Review of USP 9,006,224
`
`The individua1(s) signing below has the authority to execute this document
`
`on behalf 0 Roxane Laboratories, Inc.
`
`
`
`
`
`
`
`Roxane Laboratories, Inc.
`Inter Partes Review of USP 9,006,224
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies on July 19, 2016, copies of the foregoing
`
`
`
`
`
`Petitioner Roxane Laboratories, Inc.’s Power Of Attorney For Petition For Inter
`
`Partes Review Of U.S. Patent No. 9,006,224 (“the ’224 patent”) were served on the
`
`Patent Owner by serving via overnight delivery the correspondence address of
`
`record for the owners of the ’224 patent and litigation counsel for Novartis AG in
`
`C.A. No. 15-474-RGA, D. Del., and via Federal Express International Priority
`
`Novartis AG:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`Attn: Peter J. Waibel, Esq. (Head of Patent Litigation)
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`
`Nicholas Kallas
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`
`Novartis International AG Novartis Campus
`Attn: Alisa A. Harbin, Esq. (Head, Group Litigation and
`Intellectual Property)
`Forum 1-1.20
`Basel, CH-4002 SWITZERLAND
`
`By: /Keith A. Zullow/
`Keith A. Zullow
`(Reg. No. 37,975)
`GOODWIN PROCTER LLP
`
`
`
`
`
`Date: July 19, 2016
`
`
`
`
`
`Roxane Laboratories, Inc.
`Inter Partes Review of USP 9,006,224
`
`
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`Tel: 212-813-8846
`Fax: 646-558-4226
`kzullow@goodwinprocter.com
`
`Counsel for Petitioner Roxane
`Laboratories, Inc.